Key statistics
As of last trade, Immuron Ltd (ANWA:STU) traded at 1.88, 32.39% above the 52 week low of 1.42 set on Mar 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.88 |
---|---|
High | 1.88 |
Low | 1.88 |
Bid | 1.43 |
Offer | 1.92 |
Previous close | 1.83 |
Average volume | 0.00 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Announcements
- Immuron CEO, Steven Lydeamore participation in Maxim Virtual Healthcare Conference
- Immuron Travelan® continued strong sales growth
- NMRC Reports Results for Campylobacter Controlled Human Infection Model Study
- Immuron Plans Phase 2 Trial for IMM-529 following FDA review
- Immuron Announces New U.S. Department of Defense Research Award for Naval Medical Research Command and Walter Reed Army Institute of Research to advance Travelan®
- Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
- Immuron CEO, Steven Lydeamore to host webinar on MarketOpen Direct Connect
- Immuron announces record Travelan® sales globally, Australia and USA
- Immuron requests pre-IND meeting for IMM-529 with FDA filing
- Immuron CEO Steven Lydeamore to present at Peak Sky High
More ▼